One-Year Survival Following Early Revascularization for Cardiogenic Shock

Abstract

For patients with AMI complicated by CS, ERV resulted in improved 1-year survival. We recommend rapid transfer of patients with AMI complicated by CS, particularly those younger than 75 years, to medical centers capable of providing early angiography and revascularization procedures.

Comparison of 30-Day Mortality between Anterior-Wall versus Inferior-Wall ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock in Patients Undergoing Primary Coronary Angioplasty

“…One important finding in the current study was the fact that, compared with previous studies [1,2] on conservative treatment, aggressive coronary intervention using primary PCI remarkably reduced 30-day mortality in patients with STEMI complicated by cardiogenic shock. Therefore, our results were consistent with those of the SHOCK Investigators [8] and other reports [3,5,6,7] that have demonstrated improvements in both short- and long-term survival in patients with AMI complicated by cardiogenic shock after primary PCI.…”

One-Year Outcomes after PCI Strategies in Cardiogenic Shock

“…2,18,19 Mortality between 30 days and 1 year was 6.6% in the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial and 12.3% in the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. 20,21 These rates are similar to the 6.6% mortality between 30 days and 1 year that was reported in this trial. The results of the landmark analysis showed a benefit of culprit-lesion-only PCI over multivessel PCI with respect to short-term mortality, and there was no statistical difference between the two groups in mortality thereafter.…”

One-Year Outcomes after PCI Strategies in Cardiogenic Shock

“…Coronaries for Cardiogenic Shock (SHOCK) trial and 12.3% in the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. 20,21 These rates are similar to the 6.6% mortality between 30 days and 1 year that was reported in this trial. The results of the landmark analysis showed a benefit of culprit-lesion-only PCI over multivessel PCI with respect to short-term mortality, and there was no statistical difference between the two groups in mortality thereafter.…”